TNF and inflammatory bowel disease: That enhanced TNF production (e.g. 160% of wild type levels, as observed in Il10−/− mice) cannot prevent the development of IBD under conditions of massive mucosal barrier compromise (e.g. NSAID exposure or helicobacter infection) further suggests that the roles of TNF in barrier maintenance vs. inflammation are potentially separable.